New York Presbyterian Hospital — New York, New York

New York Presbyterian Hospital is a clinical research site located in New York, New York, United States 10065-4870.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

New York Presbyterian Hospital has participated in 111 clinical trials with 17 currently active.

Therapeutic areas: Beta-Thalassemia, Graft Versus Host Disease, Ulcerative Colitis.

Sponsors: Celgene, Mesoblast, Inc., Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian Hospital?

New York Presbyterian Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian Hospital conducted?

New York Presbyterian Hospital has 111 clinical trials on record, with 17 currently active. Their work covers Beta-Thalassemia, Graft Versus Host Disease, Ulcerative Colitis.

Is New York Presbyterian Hospital accredited by Crixeo Health?

Yes — New York Presbyterian Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York Presbyterian Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.